BIOX
Bioceres Crop·NASDAQ
--
--(--)
--
--(--)
9.05 / 10
Outperform
The fundamental assessment for Bioceres Crop (BIOX) is outstanding with a score of 9.05/10. Key strengths include PB-ROE (value -0.9267 in group 4), Asset-MV (value -0.5007 in group 2), Revenue-MV (value 1.2341 in group 1), and Profit-MV (value 0.4634 in group 2), all contributing positively to the overall score. Limitations arise from Cash-UP (value -0.0574 in group 1) and Cash-MV (value 1.6944 in group 3) with negative weights, indicating cash-flow and liquidity concerns. Despite these drawbacks, the strong asset quality and profitability suggest resilient fundamentals, though cash-flow risks warrant monitoring.
Analysis Checks(5/10)
Revenue-MV
Value1.23
Score2/3
Weight19.56%
1M Return2.48%
Value1.23
Score2/3
Weight19.56%
1M Return2.48%
Net profit attributable to parent company shareholders / Net profit (%)
Value94.17
Score0/3
Weight-2.39%
1M Return-0.30%
Value94.17
Score0/3
Weight-2.39%
1M Return-0.30%
Net income-Revenue
Value-0.17
Score2/3
Weight6.08%
1M Return0.74%
Value-0.17
Score2/3
Weight6.08%
1M Return0.74%
Total profit / EBIT (%)
Value180.24
Score0/3
Weight-25.59%
1M Return-3.85%
Value180.24
Score0/3
Weight-25.59%
1M Return-3.85%
Asset-MV
Value-0.50
Score2/3
Weight23.41%
1M Return3.44%
Value-0.50
Score2/3
Weight23.41%
1M Return3.44%
Net assets per share (growth rate compared to beginning of year %)
Value-16.25
Score1/3
Weight7.14%
1M Return0.84%
Value-16.25
Score1/3
Weight7.14%
1M Return0.84%
Profit-MV
Value0.46
Score3/3
Weight61.02%
1M Return5.77%
Value0.46
Score3/3
Weight61.02%
1M Return5.77%
PB-ROE
Value-0.93
Score3/3
Weight30.92%
1M Return3.54%
Value-0.93
Score3/3
Weight30.92%
1M Return3.54%
Cash-UP
Value-0.06
Score1/3
Weight-18.67%
1M Return-2.49%
Value-0.06
Score1/3
Weight-18.67%
1M Return-2.49%
Cash-MV
Value1.69
Score1/3
Weight-1.47%
1M Return-0.16%
Value1.69
Score1/3
Weight-1.47%
1M Return-0.16%
Revenue-MV
Value1.23
Score2/3
Weight19.56%
1M Return2.48%
Value1.23
Score2/3
Weight19.56%
1M Return2.48%
Net assets per share (growth rate compared to beginning of year %)
Value-16.25
Score1/3
Weight7.14%
1M Return0.84%
Value-16.25
Score1/3
Weight7.14%
1M Return0.84%
Net profit attributable to parent company shareholders / Net profit (%)
Value94.17
Score0/3
Weight-2.39%
1M Return-0.30%
Value94.17
Score0/3
Weight-2.39%
1M Return-0.30%
Profit-MV
Value0.46
Score3/3
Weight61.02%
1M Return5.77%
Value0.46
Score3/3
Weight61.02%
1M Return5.77%
Net income-Revenue
Value-0.17
Score2/3
Weight6.08%
1M Return0.74%
Value-0.17
Score2/3
Weight6.08%
1M Return0.74%
PB-ROE
Value-0.93
Score3/3
Weight30.92%
1M Return3.54%
Value-0.93
Score3/3
Weight30.92%
1M Return3.54%
Total profit / EBIT (%)
Value180.24
Score0/3
Weight-25.59%
1M Return-3.85%
Value180.24
Score0/3
Weight-25.59%
1M Return-3.85%
Cash-UP
Value-0.06
Score1/3
Weight-18.67%
1M Return-2.49%
Value-0.06
Score1/3
Weight-18.67%
1M Return-2.49%
Asset-MV
Value-0.50
Score2/3
Weight23.41%
1M Return3.44%
Value-0.50
Score2/3
Weight23.41%
1M Return3.44%
Cash-MV
Value1.69
Score1/3
Weight-1.47%
1M Return-0.16%
Value1.69
Score1/3
Weight-1.47%
1M Return-0.16%
Is BIOX undervalued or overvalued?
- BIOX scores 9.05/10 on fundamentals and holds a Discounted valuation at present. Backed by its -2.51% ROE, -18.92% net margin, -0.63 P/E ratio, 0.12 P/B ratio, and -2337.69% earnings growth, these metrics solidify its Outperform investment rating.
